NON-METASTATIC PROSTATE CANCER
Clinical trials for NON-METASTATIC PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-METASTATIC PROSTATE CANCER trials appear
Sign up with your email to follow new studies for NON-METASTATIC PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two-Pill attack on tough prostate cancer shows early promise
Disease control OngoingThis early-stage study tests two oral drugs (darolutamide and abemaciclib) plus standard hormone therapy in men with high-risk prostate cancer that has spread or may come back. The first part finds the safest dose; the second part checks if the combination can shrink tumors befor…
Matched conditions: NON-METASTATIC PROSTATE CANCER
Phase: PHASE1 • Sponsor: Praful Ravi, MB BCHir, MRCP • Aim: Disease control
Last updated May 26, 2026 08:54 UTC
-
Which prostate cancer drug is kinder to your brain?
Knowledge-focused OngoingThis study looks at how two different prostate cancer medications, darolutamide and enzalutamide, affect thinking skills like memory and attention. About 111 men with advanced prostate cancer will take one of the two drugs and complete computer-based brain tests over time. The go…
Matched conditions: NON-METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC